{"id":"W1506450640","doi":"10.1016/s2213-2600(15)00197-6","title":"Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial","year":2015,"lang":"en","type":"article","venue":"The Lancet Respiratory Medicine","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":366,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; University of Calgary","funders":"National Institutes of Health; MedImmune; National Institute for Health and Care Research; Wellcome Trust","keywords":"Medicine; Asthma; Placebo; Population; Exacerbation; Clinical endpoint; Formoterol; Randomized controlled trial; Adverse effect; Intention-to-treat analysis; Placebo-controlled study; Clinical trial; Physical therapy; Internal medicine; Pediatrics; Double blind; Budesonide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002483418,0.0004283922,0.00248741,0.0002758233,0.00009548313,0.00001284336,0.0002463912,0.0001601194,0.0001033281],"category_scores_gemma":[0.0009305476,0.0002070312,0.0001389267,0.0004406447,0.0005995113,0.000115357,0.00004998524,0.0004713726,0.000006892275],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001024232,"about_ca_system_score_gemma":0.0005612578,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003013345,"about_ca_topic_score_gemma":0.00003633126,"domain_scores_codex":[0.9964142,0.0005478485,0.001122719,0.0004469624,0.0009673717,0.0005008377],"domain_scores_gemma":[0.9973339,0.0006259311,0.0005110004,0.0007207787,0.000321122,0.0004872305],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9857336,0.00110557,0.005416873,0.00009240746,0.0002938696,0.00006721138,0.0006135963,0.00006671644,0.00005689806,0.00006500691,0.001633156,0.00485507],"study_design_scores_gemma":[0.9709703,0.01184674,0.007065564,0.0004756943,0.0005365012,0.00001158137,0.0003204095,0.00004504752,0.00002778643,0.00001826512,0.008454703,0.000227383],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.983628,0.002604804,0.00002802897,0.00112935,0.0002183856,0.008588911,0.00002083247,0.00005677895,0.00372494],"genre_scores_gemma":[0.9966913,0.00002885401,0.00002186958,0.001218455,0.001486678,0.0003168553,0.00002989839,0.00004536347,0.0001607525],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0147633,"threshold_uncertainty_score":0.844249,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04495044110274853,"score_gpt":0.3217763188468193,"score_spread":0.2768258777440708,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}